PAM16 and prostate cancer: In addition, analysis of copy number alterations (CNA) data of the prostate cancer patient samples available from cBioPortal showed amplification of Magmas (Figure 2D, Supplementary Table S1), and a strong positive correlation between Magmas copy number and mRNA expression (Figure 2E, Supplementary Table S1) in five datasets [23,24,25,26,27].